MX2007005238A - Una composicion veterinaria transmucosal que comprende detomidina. - Google Patents

Una composicion veterinaria transmucosal que comprende detomidina.

Info

Publication number
MX2007005238A
MX2007005238A MX2007005238A MX2007005238A MX2007005238A MX 2007005238 A MX2007005238 A MX 2007005238A MX 2007005238 A MX2007005238 A MX 2007005238A MX 2007005238 A MX2007005238 A MX 2007005238A MX 2007005238 A MX2007005238 A MX 2007005238A
Authority
MX
Mexico
Prior art keywords
transmucosal
detomidine
composition
veterinary composition
semisolid
Prior art date
Application number
MX2007005238A
Other languages
English (en)
Inventor
Mirja Huhtinen
Piritta Koistinen
Lasse Leino
Maria Rantala
Helena Kaukinen
Kaija Af Ursin
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of MX2007005238A publication Critical patent/MX2007005238A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Abstract

La presente invencion se relaciona con una composicion veterinaria en una forma semisolida adaptada para administracion transmucosal para proporcionar sedacion y analgesia en animales de gran tamano tales como por ejemplo, caballo y ganado vacuno. La composicion transmucosal semisolida de la invencion comprende detomidina o una sal farmaceuticamente aceptable de la misma como una ingrediente activo. La composicion proporciona una accion rapida mientras que tenga un bajo potencial de irritacion en la mucosa oral.
MX2007005238A 2004-11-05 2005-11-03 Una composicion veterinaria transmucosal que comprende detomidina. MX2007005238A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62512904P 2004-11-05 2004-11-05
FI20041425A FI20041425A0 (fi) 2004-11-05 2004-11-05 Transmukosaalinen veterinäärinen koostumus
PCT/FI2005/000470 WO2006048501A1 (en) 2004-11-05 2005-11-03 A transmucosal veterinary composition comprising detomidine

Publications (1)

Publication Number Publication Date
MX2007005238A true MX2007005238A (es) 2007-07-09

Family

ID=33515193

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007005238A MX2007005238A (es) 2004-11-05 2005-11-03 Una composicion veterinaria transmucosal que comprende detomidina.

Country Status (22)

Country Link
US (2) US7863311B2 (es)
EP (1) EP1811995B1 (es)
JP (1) JP4996472B2 (es)
KR (1) KR101257672B1 (es)
AR (1) AR054987A1 (es)
AU (1) AU2005300451B2 (es)
BR (1) BRPI0517719B1 (es)
CA (1) CA2583876C (es)
DK (1) DK1811995T3 (es)
ES (1) ES2388442T3 (es)
FI (1) FI20041425A0 (es)
HR (1) HRP20120856T1 (es)
IL (1) IL182541A (es)
MX (1) MX2007005238A (es)
NO (1) NO338158B1 (es)
NZ (1) NZ554521A (es)
PL (1) PL1811995T3 (es)
PT (1) PT1811995E (es)
RS (1) RS52504B (es)
SI (1) SI1811995T1 (es)
WO (1) WO2006048501A1 (es)
ZA (1) ZA200703486B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100784134B1 (ko) 2006-10-09 2007-12-12 주식회사 대웅 상피세포성장인자를 함유하는 안정한 구내염 치료용 액상조성물
PT2079456E (pt) * 2007-04-04 2013-03-13 Sigmoid Pharma Ltd Composições farmacêuticas de ciclosporina
US20090246256A1 (en) * 2008-03-27 2009-10-01 Al-Ghananeem Abeer M Compositions and Methods for Transmucosal Delivery of Lofexidine
KR101517415B1 (ko) 2008-05-14 2015-05-07 에스케이바이오팜 주식회사 난용성 항경련제를 함유하는 경비 항경련성 약학 조성물
WO2011027811A1 (ja) * 2009-09-04 2011-03-10 株式会社 資生堂 Ｏ／ｗ乳化組成物の製造方法
US8722636B2 (en) 2011-01-31 2014-05-13 New Market Pharmaceuticals, LLC Animal treatments
US10064849B2 (en) 2012-05-02 2018-09-04 New Market Pharmaceuticals Pharmaceutical compositions for direct systemic introduction
BR112014027352B1 (pt) 2012-05-02 2022-10-25 New Market Pharmaceuticals Composições farmacêuticas para a introdução sistêmica direta
FR2990134B1 (fr) * 2012-05-07 2014-11-21 Anaconda Pharma Composition pharmaceutique d'un inhibiteur du virus du papillome
LT2906213T (lt) * 2012-10-15 2018-02-26 Orion Corporation Baimės triukšmui palengvinimo veterinarinis būdas
MX2015007794A (es) * 2012-12-21 2015-09-04 Teva Pharma Suministro transmucosal de acetato de glatiramer mediante parches orales.
FI127534B (en) * 2014-11-10 2018-08-31 Vetcare Oy Substituted benzoefuroquinolizine and ɑ2-adrenergic agonist comprising compositions
MX2019008115A (es) * 2017-01-06 2019-10-24 Clexio Biosciences Ltd Formulaciones topicas de detomidina.
EP3820448A2 (en) * 2018-07-11 2021-05-19 Clexio Biosciences Ltd. Topical detomidine formulations
KR20220002950A (ko) 2019-05-01 2022-01-07 클렉시오 바이오사이언시스 리미티드 소양증의 치료 방법
US20220249465A1 (en) * 2019-05-31 2022-08-11 Primo Pharmatech Llc Unit dosage form for transmucosal drug delivery of an active pharmaceutical ingredient

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
GB2256135B (en) * 1991-05-31 1995-01-18 Orion Yhtymae Oy Transdermal administration of 4-substituted imidazoles
MX9304075A (es) * 1992-07-08 1994-04-29 Applied Research Systems Composicion farmaceutica para el tratamiento o profilaxis de los desordenes trombohemorragicos consuntivos.
CN1106259A (zh) * 1994-02-05 1995-08-09 日东制药株式会社 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂
EP1021204B1 (en) * 1997-09-26 2005-12-28 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
JP2002526403A (ja) * 1998-10-02 2002-08-20 スリーエム イノベイティブ プロパティズ カンパニー 粘膜を起点としたデリバリーシステムおよび動物への適用
US7001609B1 (en) * 1998-10-02 2006-02-21 Regents Of The University Of Minnesota Mucosal originated drug delivery systems and animal applications
AU2001282064B2 (en) 2000-08-03 2007-02-01 Antares Pharma Ipl Ag Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
JP4493203B2 (ja) 2000-12-12 2010-06-30 株式会社ブリヂストン 空気入りタイヤの製造方法
DE10107659B4 (de) * 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin
DE10256774A1 (de) * 2002-12-05 2004-06-24 Lts Lohmann Therapie-Systeme Ag Transmucosale und transdermale Arzneimittel mit verbesserter Wirkstoffresorption

Also Published As

Publication number Publication date
CA2583876A1 (en) 2006-05-11
SI1811995T1 (sl) 2012-10-30
CA2583876C (en) 2012-05-29
KR20070085284A (ko) 2007-08-27
RS52504B (en) 2013-04-30
DK1811995T3 (da) 2012-08-20
ES2388442T3 (es) 2012-10-15
AU2005300451A1 (en) 2006-05-11
JP2008519012A (ja) 2008-06-05
FI20041425A0 (fi) 2004-11-05
IL182541A0 (en) 2007-09-20
PL1811995T3 (pl) 2012-12-31
NZ554521A (en) 2010-09-30
US8309591B2 (en) 2012-11-13
ZA200703486B (en) 2008-06-25
EP1811995B1 (en) 2012-07-25
EP1811995A1 (en) 2007-08-01
NO20072864L (no) 2007-06-05
KR101257672B1 (ko) 2013-04-24
BRPI0517719B1 (pt) 2018-11-06
JP4996472B2 (ja) 2012-08-08
WO2006048501A1 (en) 2006-05-11
IL182541A (en) 2011-02-28
US20110071203A1 (en) 2011-03-24
NO338158B1 (no) 2016-08-01
BRPI0517719A (pt) 2008-10-21
US7863311B2 (en) 2011-01-04
AR054987A1 (es) 2007-08-01
PT1811995E (pt) 2012-08-03
HRP20120856T1 (hr) 2012-11-30
US20070299121A1 (en) 2007-12-27
AU2005300451B2 (en) 2011-01-20

Similar Documents

Publication Publication Date Title
MX2007005238A (es) Una composicion veterinaria transmucosal que comprende detomidina.
UA90858C2 (ru) Композиция с контролируемым высвобождением варденафила
AU2003301190A8 (en) Administration of capsaicinoids
EP1848270A4 (en) TRANSMUCOSAL ADMINISTRATION OF MEDICINAL PREPARATIONS FOR THE TREATMENT AND PREVENTION OF DISEASES IN ANIMALS
MXPA05010565A (es) Sistemas de suminsitro de farmacos que comprenden un ingrediente activo encapsulado.
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
DK1317419T3 (da) Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
MXPA05008838A (es) Formulaciones de absorcion acelerada del agonista selectivo de la 5-ht.
MX2007005570A (es) Metodos y composiciones que usan compuestos inmunomoduladores para el tratamiento y manejo de padecimientos parasiticos.
MXPA05006670A (es) Administracion de capsaicinoides.
MY144477A (en) Galenic formulations of organic compounds
EP1708685A4 (en) GALENIC FORMS OF EFFERVESCENT ORAL OPIATES AND METHODS OF ADMINISTERING OPIATES
DE602004017127D1 (de) Langandauernde, aromatisierte darreichungsform zur verlängerten freisetzung von aktivstoffen im mund
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
BR0201719A (pt) Composições farmacêuticas agradáveis ao paladar para animais de companhia
MX2009002314A (es) Composiciones farmaceuticas que comprenden hgh para suministro oral.
TW200603787A (en) Topical preparations containing ambroxol
SG147450A1 (en) Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
UA92498C2 (ru) Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм
BR0214497A (pt) Composição farmacêutica que compreende um agonista do receptor 5ht1
MXPA05013270A (es) Forma de administracion transmucosal con irritacion mucosal reducida. reducida.
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
SE0203817D0 (sv) New composition
ATE477021T1 (de) 1,3,5-triazepin-dionen zur behandlung von malaria
CY1113730T1 (el) Μια δiαβλεννογονiκη κτηνιατρικη συνθεση η οποια περιλαμβανει δετομιδινη

Legal Events

Date Code Title Description
FG Grant or registration